Yarrow Bioscience YARW
NASDAQ YARW
$28.16 -0.95 (-3.26%)
As of: Sep 10, 2026 · 1:32 PM EDT

Yarrow Bioscience (YARW) Asset Utilization Ratio (2018 - 2026)

Yarrow Bioscience's (YARW) quarterly Asset Utilization Ratio came in at 0.02 in Q2 2026, up 102.4% on a YoY basis from 0.01 in Q2 2025, and up 16.98% quarter-over-quarter from 0.02 in Q1 2026.

Analysis

Yarrow Bioscience (YARW) Asset Utilization Ratio (2018 - 2026) Analysis & Trends

Yarrow Bioscience (YARW) has reported Asset Utilization Ratio for 9 consecutive years, with 0.02 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Asset Utilization Ratio rose 102.4% year-over-year to 0.02; the trailing twelve-month figure through Jun 2026 stood at 0.02 (up 102.4% YoY), and the FY2025 full-year result was 0.01, up 103.07% from the prior year.
  • Asset Utilization Ratio climbed to 0.02 in Q2 2026 per YARW's latest filing, from 0.02 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.02 in Q2 2026 and bottomed at 0.0 in Q1 2024.
  • Historically, Asset Utilization Ratio has averaged 0.01 across 5 years, with a median of 0.01 in 2022.
  • The sharpest annual moves came in 2022 and 2025: Asset Utilization Ratio tumbled 91.65% in 2022, then soared 119.29% in 2025.
  • Over 5 years, Asset Utilization Ratio stood at 0.01 in 2022, then tumbled by 36.28% to 0.01 in 2023, then decreased by 2.89% to 0.01 in 2024, then jumped by 42.05% to 0.01 in 2025, then jumped by 102.4% to 0.02 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.02, 0.02, and 0.01 for Q2 2026, Q1 2026, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 642.34 Bn 621.58 Bn 17.26 Bn 0.49
2 AbbVie 446.74 Bn 440.17 Bn 12.70 Bn 0.47
3 Merck 357.89 Bn 350.75 Bn 12.21 Bn 0.52
4 Novartis Ag 267.44 Bn 259.75 Bn 11.24 Bn 0.57
5 Pfizer 156.55 Bn 144.85 Bn 10.94 Bn 0.31
6 Sanofi 52.21 Bn 44.83 Bn 10.79 Bn 0.36
7 Revolution Medicines 42.85 Bn 42.85 Bn - -
8 Incyte 24.63 Bn 20.09 Bn 1.57 Bn 0.77
9 United Therapeutics 21.40 Bn 18.74 Bn 683.80 Mn 0.45
10 Yarrow Bioscience 24.16 Mn 1.24 Mn - 0.02
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.02
Mar 31, 2026 0.02
Jun 30, 2025 0.01
Mar 31, 2025 0.01
Dec 31, 2024 0.01
Sep 30, 2024 0.01
Jun 30, 2024 0.01
Mar 31, 2024 0.00
Dec 31, 2023 0.01
Sep 30, 2023 0.02
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.01
Jun 30, 2022 0.01
Mar 31, 2022 0.01
Dec 31, 2021 0.01
Sep 30, 2021 0.05
Jun 30, 2021 0.06
Mar 31, 2021 0.16